{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:20:57Z","timestamp":1794262857015,"version":"4.9.0"},"reference-count":196,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:p>Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a rare but potentially lethal inherited arrhythmia syndrome. It is characterized by exercise- or emotion-induced bidirectional or polymorphic ventricular tachycardia, which can lead to recurrent syncope and even sudden death. CPVT is mainly caused by mutations in genes related to calcium homeostasis regulation, with ryanodine receptor 2 and calsequestrin 2 gene mutations being the most common. In recent years, with the development of molecular biology techniques and in-depth clinical research, the understanding of CPVT has been continuously deepened. This review summarizes the latest advances in CPVT research, focusing on molecular genetic mechanisms, pathogenesis, clinical manifestations, diagnostic approaches, and treatment strategies. We examine the complex interplay between genetic mutations and arrhythmogenic mechanisms, highlighting insights from heterologous, animal, and human induced pluripotent stem cell-derived models. The review also addresses current therapeutic approaches, from pharmacological interventions to device therapy and sympathetic denervation, while exploring future research directions that may lead to improved patient outcomes through gene-specific and precision medicine approaches.<\/jats:p>","DOI":"10.1097\/ah9.0000000000000018","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:00:22Z","timestamp":1761141622000},"page":"97-110","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Catecholaminergic polymorphic ventricular tachycardia: A narrative review of recent advances in genetics, mechanisms, diagnosis, and treatment"],"prefix":"10.1097","volume":"1","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2113-9650","authenticated-orcid":false,"given":"Shuai","family":"Luo","sequence":"first","affiliation":[{"name":"Inserm, UMR-S 1180, Laboratory of Signalling and Cardiovascular Pathophysiology, Universit\u00e9 Paris-Saclay, Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0009-2884","authenticated-orcid":false,"given":"Ana Mar\u00eda","family":"G\u00f3mez","sequence":"additional","affiliation":[{"name":"Inserm, UMR-S 1180, Laboratory of Signalling and Cardiovascular Pathophysiology, Universit\u00e9 Paris-Saclay, Orsay, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"R1-20260203","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3390\/jcm13061781","article-title":"Catecholaminergic polymorphic ventricular tachycardia: clinical characteristics, diagnostic evaluation and therapeutic strategies.","volume":"13","author":"Aggarwal","year":"2024","journal-title":"J Clin Med"},{"key":"R2-20260203","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41569-019-0266-2","article-title":"Epidemiology of inherited arrhythmias.","volume":"17","author":"Offerhaus","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R3-20260203","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.15420\/aer.2022.09","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"11","author":"Abbas","year":"2022","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R4-20260203","first-page":"e47974","article-title":"Catecholaminergic polymorphic ventricular tachycardia and gene therapy: a comprehensive review of the literature.","volume":"15","author":"Henriquez","year":"2023","journal-title":"Cureus"},{"key":"R5-20260203","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ccep.2023.04.002","article-title":"Catecholaminergic polymorphic ventricular tachycardia: a review of therapeutic strategies.","volume":"15","author":"Bergeman","year":"2023","journal-title":"Card Electrophysiol Clin"},{"key":"R6-20260203","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1006\/geno.1993.1357","article-title":"Chromosome mapping of five human cardiac and skeletal muscle sarcoplasmic reticulum protein genes.","volume":"17","author":"Otsu","year":"1993","journal-title":"Genomics"},{"key":"R7-20260203","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","article-title":"Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.","volume":"103","author":"Laitinen","year":"2001","journal-title":"Circulation"},{"key":"R8-20260203","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ceca.2015.12.002","article-title":"Calcium signaling in human stem cell-derived cardiomyocytes: evidence from normal subjects and CPVT afflicted patients.","volume":"59","author":"Zhang","year":"2016","journal-title":"Cell Calcium"},{"key":"R9-20260203","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/CIRCRESAHA.111.256560","article-title":"Abnormal termination of Ca2+ release is a common defect of RyR2 mutations associated with cardiomyopathies.","volume":"110","author":"Tang","year":"2012","journal-title":"Circ Res"},{"key":"R10-20260203","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s11033-019-05201-y","article-title":"Mutation-specific differences in arrhythmias and drug responses in CPVT patients: simultaneous patch clamp and video imaging of iPSC derived cardiomyocytes.","volume":"47","author":"P\u00f6l\u00f6nen","year":"2020","journal-title":"Mol Biol Rep"},{"key":"R11-20260203","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.stemcr.2022.07.002","article-title":"Characterization of N-terminal RYR2 variants outside CPVT1 hotspot regions using patient iPSCs reveal pathogenesis and therapeutic potential.","volume":"17","author":"Stutzman","year":"2022","journal-title":"Stem Cell Rep"},{"key":"R12-20260203","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1042\/BJ20071287","article-title":"Endoplasmic reticulum Ca2+ measurements reveal that the cardiac ryanodine receptor mutations linked to cardiac arrhythmia and sudden death alter the threshold for store-overload-induced Ca2+ release.","volume":"412","author":"Jones","year":"2008","journal-title":"Biochem J"},{"key":"R13-20260203","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+\/calmodulin-dependent kinase II.","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"key":"R14-20260203","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1111\/jcmm.16521","article-title":"Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia.","volume":"25","author":"Word","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R15-20260203","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/CIRCRESAHA.111.244970","article-title":"A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium.","volume":"109","author":"Meli","year":"2011","journal-title":"Circ Res"},{"key":"R16-20260203","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1042\/BJ20130594","article-title":"The CPVT-associated RyR2 mutation G230C enhances store overload-induced Ca2+ release and destabilizes the N-terminal domains.","volume":"454","author":"Liu","year":"2013","journal-title":"Biochem J"},{"key":"R17-20260203","doi-asserted-by":"crossref","first-page":"e0184177","DOI":"10.1371\/journal.pone.0184177","article-title":"CPVT-associated cardiac ryanodine receptor mutation G357S with reduced penetrance impairs Ca2+ release termination and diminishes protein expression.","volume":"12","author":"Liu","year":"2017","journal-title":"PLoS One"},{"key":"R18-20260203","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2015.03.033","article-title":"Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.","volume":"12","author":"Wang\u00fcemert","year":"2015","journal-title":"Heart Rhythm"},{"key":"R19-20260203","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/emmm.201100194","article-title":"Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Jung","year":"2012","journal-title":"EMBO Mol Med"},{"key":"R20-20260203","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jacbts.2017.06.008","article-title":"Suppression of arrhythmia by enhancing mitochondrial Ca2+ uptake in catecholaminergic ventricular tachycardia models.","volume":"2","author":"Schweitzer","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"R21-20260203","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bbrc.2014.08.132","article-title":"A knock-in mouse model of N-terminal R420W mutation of cardiac ryanodine receptor exhibits arrhythmogenesis with abnormal calcium dynamics in cardiomyocytes.","volume":"452","author":"Okudaira","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"R22-20260203","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.recesp.2014.04.025","article-title":"Non-ventricular, clinical, and functional features of the RyR2(R420Q) mutation causing catecholaminergic polymorphic ventricular tachycardia.","volume":"68","author":"Domingo","year":"2015","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"R23-20260203","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/jcmm.12581","article-title":"Functional abnormalities in iPSC-derived cardiomyocytes generated from CPVT1 and CPVT2 patients carrying ryanodine or calsequestrin mutations.","volume":"19","author":"Novak","year":"2015","journal-title":"J Cell Mol Med"},{"key":"R24-20260203","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1161\/CIRCRESAHA.121.319094","article-title":"Impaired binding to junctophilin-2 and nanostructural alteration in CPVT mutation.","volume":"129","author":"Yin","year":"2021","journal-title":"Circ Res"},{"key":"R25-20260203","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.hrthm.2020.09.007","article-title":"Calcium signaling consequences of RyR2 mutations associated with CPVT1 introduced via CRISPR\/Cas9 gene editing in human-induced pluripotent stem cell-derived cardiomyocytes: comparison of RyR2-R420Q, F2483I, and Q4201R.","volume":"18","author":"Zhang","year":"2021","journal-title":"Heart Rhythm"},{"key":"R26-20260203","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.yjmcc.2025.07.014","article-title":"Compromised repolarization reserve in a murine model of catecholaminergic polymorphic ventricular tachycardia caused by RyR2-R420Q mutation.","volume":"206","author":"Zissimopoulos","year":"2025","journal-title":"J Mol Cell Cardiol"},{"key":"R27-20260203","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.0000192146.85173.4b","article-title":"Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death.","volume":"97","author":"Jiang","year":"2005","journal-title":"Circ Res"},{"key":"R28-20260203","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCRESAHA.112.273342","article-title":"Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia.","volume":"111","author":"Shan","year":"2012","journal-title":"Circ Res"},{"key":"R29-20260203","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/cvr\/cvu240","article-title":"Dantrolene rescues aberrant N-terminus intersubunit interactions in mutant pro-arrhythmic cardiac ryanodine receptors.","volume":"105","author":"Seidel","year":"2015","journal-title":"Cardiovasc Res"},{"key":"R30-20260203","doi-asserted-by":"crossref","first-page":"102500","DOI":"10.1016\/j.ceca.2021.102500","article-title":"Mutation in RyR2-FKBP binding site alters Ca2+ signaling modestly but increases \u201carrhythmogenesis\u201d in human stem cells derived cardiomyocytes.","volume":"101","author":"Fern\u00e1ndez-Morales","year":"2022","journal-title":"Cell Calcium"},{"key":"R31-20260203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1440-1681.13722","article-title":"A gain of function ryanodine receptor 2 mutation (R1760W-RyR2) in catecholaminergic polymorphic ventricular tachycardia.","volume":"50","author":"Li","year":"2023","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R32-20260203","doi-asserted-by":"crossref","first-page":"20220175","DOI":"10.1098\/rstb.2022.0175","article-title":"Patient-specific induced pluripotent stem cell properties implicate Ca2+-homeostasis in clinical arrhythmia associated with combined heterozygous RYR2 and SCN10A variants.","volume":"378","author":"Zhou","year":"2023","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"R33-20260203","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ijcard.2009.08.041","article-title":"Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro.","volume":"147","author":"Marjamaa","year":"2011","journal-title":"Int J Cardiol"},{"key":"R34-20260203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/01.RES.0000091335.07574.86","article-title":"Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes.","volume":"93","author":"George","year":"2003","journal-title":"Circ Res"},{"key":"R35-20260203","doi-asserted-by":"crossref","first-page":"e843","DOI":"10.1038\/cddis.2013.369","article-title":"CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Di Pasquale","year":"2013","journal-title":"Cell Death Dis"},{"key":"R36-20260203","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.CIR.0000132472.98675.EC","article-title":"Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.","volume":"109","author":"Lehnart","year":"2004","journal-title":"Circulation"},{"key":"R37-20260203","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cvr\/cvq229","article-title":"Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts.","volume":"89","author":"Zhang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"R38-20260203","doi-asserted-by":"crossref","first-page":"e44660","DOI":"10.1371\/journal.pone.0044660","article-title":"Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.","volume":"7","author":"Kujala","year":"2012","journal-title":"PLoS One"},{"key":"R39-20260203","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/apha.12006","article-title":"Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts.","volume":"207","author":"King","year":"2013","journal-title":"Acta Physiol (Oxf)"},{"key":"R40-20260203","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1093\/cvr\/cvt141","article-title":"Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation.","volume":"99","author":"King","year":"2013","journal-title":"Cardiovasc Res"},{"key":"R41-20260203","doi-asserted-by":"crossref","first-page":"e0125366","DOI":"10.1371\/journal.pone.0125366","article-title":"Antiarrhythmic effects of dantrolene in patients with catecholaminergic polymorphic ventricular tachycardia and replication of the responses using iPSC models.","volume":"10","author":"Penttinen","year":"2015","journal-title":"PLoS One"},{"key":"R42-20260203","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/europace\/euv380","article-title":"Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.","volume":"18","author":"Paavola","year":"2016","journal-title":"Europace"},{"key":"R43-20260203","doi-asserted-by":"crossref","first-page":"jcs229039","DOI":"10.1242\/jcs.229039","article-title":"Ion channel gating in cardiac ryanodine receptors from the arrhythmic RyR2-P2328S mouse.","volume":"132","author":"Salvage","year":"2019","journal-title":"J Cell Sci"},{"key":"R44-20260203","doi-asserted-by":"crossref","first-page":"873531","DOI":"10.3389\/fbioe.2022.873531","article-title":"Identifying features of cardiac disease phenotypes based on mechanical function in a catecholaminergic polymorphic ventricular tachycardia model.","volume":"10","author":"Stempien","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"R45-20260203","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000335753","article-title":"In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.","volume":"28","author":"Fatima","year":"2011","journal-title":"Cell Physiol Biochem"},{"key":"R46-20260203","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ceca.2013.04.004","article-title":"Ca2+ signaling in human induced pluripotent stem cell-derived cardiomyocytes (iPS-CM) from normal and catecholaminergic polymorphic ventricular tachycardia (CPVT)-afflicted subjects.","volume":"54","author":"Zhang","year":"2013","journal-title":"Cell Calcium"},{"key":"R47-20260203","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceca.2018.04.009","article-title":"CRISPR\/Cas9 gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling.","volume":"73","author":"Wei","year":"2018","journal-title":"Cell Calcium"},{"key":"R48-20260203","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1161\/CIRCRESAHA.109.209312","article-title":"Catecholaminergic polymorphic ventricular tachycardia is caused by mutation-linked defective conformational regulation of the ryanodine receptor.","volume":"106","author":"Uchinoumi","year":"2010","journal-title":"Circ Res"},{"key":"R49-20260203","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.bbrc.2010.03.046","article-title":"Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.","volume":"394","author":"Xu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"R50-20260203","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1253\/circj.CJ-10-0680","article-title":"Dantrolene, a therapeutic agent for malignant hyperthermia, inhibits catecholaminergic polymorphic ventricular tachycardia in a RyR2(R2474S\/+) knock-in mouse model.","volume":"74","author":"Kobayashi","year":"2010","journal-title":"Circ J"},{"key":"R51-20260203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/cvr\/cvw095","article-title":"Exercise training prevents ventricular tachycardia in CPVT1 due to reduced CaMKII-dependent arrhythmogenic Ca2+ release.","volume":"111","author":"Manotheepan","year":"2016","journal-title":"Cardiovasc Res"},{"key":"R52-20260203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.112.274803","article-title":"Heterogeneity of ryanodine receptor dysfunction in a mouse model of catecholaminergic polymorphic ventricular tachycardia.","volume":"112","author":"Loaiza","year":"2013","journal-title":"Circ Res"},{"key":"R53-20260203","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/jcm7110423","article-title":"Post-translational modifications and diastolic calcium leak associated to the novel RyR2-D3638A mutation lead to CPVT in patient-specific hiPSC-derived cardiomyocytes.","volume":"7","author":"Acimovic","year":"2018","journal-title":"J Clin Med"},{"key":"R54-20260203","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1242\/dmm.026823","article-title":"A human pluripotent stem cell model of catecholaminergic polymorphic ventricular tachycardia recapitulates patient-specific drug responses.","volume":"9","author":"Preininger","year":"2016","journal-title":"Dis Model Mech"},{"key":"R55-20260203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvad163","article-title":"Point mutations in RyR2 Ca2+-binding residues of human cardiomyocytes cause cellular remodelling of cardiac excitation contraction-coupling.","volume":"120","author":"Xia","year":"2024","journal-title":"Cardiovasc Res"},{"key":"R56-20260203","doi-asserted-by":"crossref","first-page":"eaan0724","DOI":"10.1126\/scitranslmed.aan0724","article-title":"Sarcoplasmic reticulum calcium leak contributes to arrhythmia but not to heart failure progression.","volume":"10","author":"Mohamed","year":"2018","journal-title":"Sci Transl Med"},{"key":"R57-20260203","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1073\/pnas.0402388101","article-title":"RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR).","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R58-20260203","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jacc.2012.02.066","article-title":"Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.","volume":"60","author":"Itzhaki","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R59-20260203","doi-asserted-by":"crossref","first-page":"9109503","DOI":"10.1155\/2018\/9109503","article-title":"Antiarrhythmic effects of carvedilol and flecainide in cardiomyocytes derived from catecholaminergic polymorphic ventricular tachycardia patients.","volume":"2018","author":"P\u00f6l\u00f6nen","year":"2018","journal-title":"Stem Cells Int"},{"key":"R60-20260203","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/01.RES.0000028455.36940.5E","article-title":"Enhanced basal activity of a cardiac Ca2+ release channel (ryanodine receptor) mutant associated with ventricular tachycardia and sudden death.","volume":"91","author":"Jiang","year":"2002","journal-title":"Circ Res"},{"key":"R61-20260203","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.0000235869.50747.e1","article-title":"Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model.","volume":"99","author":"Liu","year":"2006","journal-title":"Circ Res"},{"key":"R62-20260203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1161\/CIRCRESAHA.108.177493","article-title":"Increased Ca2+ sensitivity of the ryanodine receptor mutant RyR2R4496C underlies catecholaminergic polymorphic ventricular tachycardia.","volume":"104","author":"Fern\u00e1ndez-Velasco","year":"2009","journal-title":"Circ Res"},{"key":"R63-20260203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2010.10.001","article-title":"Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C\u00b1) mice with catecholaminergic polymorphic ventricular tachycardia.","volume":"50","author":"Liu","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"R64-20260203","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.stem.2015.06.014","article-title":"Robust in vitro induction of human germ cell fate from pluripotent stem cells.","volume":"17","author":"Sasaki","year":"2015","journal-title":"Cell Stem Cell"},{"key":"R65-20260203","doi-asserted-by":"crossref","first-page":"e15265","DOI":"10.14814\/phy2.15265","article-title":"Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling.","volume":"10","author":"Hopton","year":"2022","journal-title":"Physiol Rep"},{"key":"R66-20260203","doi-asserted-by":"crossref","first-page":"18309","DOI":"10.1073\/pnas.0706573104","article-title":"Loss of luminal Ca2+ activation in the cardiac ryanodine receptor is associated with ventricular fibrillation and sudden death.","volume":"104","author":"Jiang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R67-20260203","doi-asserted-by":"crossref","first-page":"E1669","DOI":"10.1073\/pnas.1419795112","article-title":"Arrhythmogenesis in a catecholaminergic polymorphic ventricular tachycardia mutation that depresses ryanodine receptor function.","volume":"112","author":"Zhao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R68-20260203","doi-asserted-by":"crossref","first-page":"15307","DOI":"10.3390\/ijms242015307","article-title":"Calcium signaling consequences of RyR2-S4938F mutation expressed in human iPSC-derived cardiomyocytes.","volume":"24","author":"Toth","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R69-20260203","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","article-title":"The RYR2-encoded ryanodine receptor\/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R70-20260203","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/CIRCRESAHA.110.226845","article-title":"Inherited dysfunction of sarcoplasmic reticulum Ca2+ handling and arrhythmogenesis.","volume":"108","author":"Priori","year":"2011","journal-title":"Circ Res"},{"key":"R71-20260203","first-page":"2230","article-title":"Leaky Ca2+ release channel\/ryanodine receptor 2 causes seizures and sudden cardiac death in mice.","volume":"118","author":"Lehnart","year":"2008","journal-title":"J Clin Invest"},{"key":"R72-20260203","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3390\/jpm11060579","article-title":"A type 2 ryanodine receptor variant in the helical domain 2 associated with an impairment of the adrenergic response.","volume":"11","author":"Blancard","year":"2021","journal-title":"J Pers Med"},{"key":"R73-20260203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"106","author":"Priori","year":"2002","journal-title":"Circulation"},{"key":"R74-20260203","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives.","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R75-20260203","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"R76-20260203","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1161\/CIRCULATIONAHA.107.711606","article-title":"Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features.","volume":"116","author":"Bhuiyan","year":"2007","journal-title":"Circulation"},{"key":"R77-20260203","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1253\/circj.CJ-19-0720","article-title":"Co-phenotype of left ventricular non-compaction cardiomyopathy and atypical catecholaminergic polymorphic ventricular tachycardia in association with R169Q, a ryanodine receptor type 2 missense mutation.","volume":"84","author":"Nozaki","year":"2020","journal-title":"Circ J"},{"key":"R78-20260203","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s10038-020-0738-6","article-title":"Classification and correlation of RYR2 missense variants in individuals with catecholaminergic polymorphic ventricular tachycardia reveals phenotypic relationships.","volume":"65","author":"Olubando","year":"2020","journal-title":"J Hum Genet"},{"issue":"Suppl 1","key":"R79-20260203","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/17431380410032517","article-title":"A missense mutation in CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.","volume":"36","author":"Lahat","year":"2004","journal-title":"Ann Med"},{"key":"R80-20260203","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12551-021-00914-6","article-title":"The function and regulation of calsequestrin-2: implications in calcium-mediated arrhythmias.","volume":"14","author":"Sibbles","year":"2022","journal-title":"Biophys Rev"},{"key":"R81-20260203","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1007\/s00018-012-1199-7","article-title":"Functional interaction between calsequestrin and ryanodine receptor in the heart.","volume":"70","author":"Gaburjakova","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"R82-20260203","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/S0006-3495(04)74271-X","article-title":"The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.","volume":"86","author":"Gyorke","year":"2004","journal-title":"Biophys J"},{"key":"R83-20260203","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ceca.2017.01.009","article-title":"Increased calcium leak associated with reduced calsequestrin expression in hyperthyroid cardiomyocytes.","volume":"62","author":"de Alba-Aguayo","year":"2017","journal-title":"Cell Calcium"},{"key":"R84-20260203","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1172\/JCI31080","article-title":"Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.","volume":"117","author":"Song","year":"2007","journal-title":"J Clin Invest"},{"key":"R85-20260203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cardiores.2007.03.002","article-title":"A mutation in calsequestrin, CASQ2D307H, impairs sarcoplasmic reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.","volume":"75","author":"Dirksen","year":"2007","journal-title":"Cardiovasc Res"},{"key":"R86-20260203","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCRESAHA.121.320661","article-title":"Impaired dynamic sarcoplasmic reticulum Ca buffering in autosomal dominant CPVT2.","volume":"131","author":"Wleklinski","year":"2022","journal-title":"Circ Res"},{"key":"R87-20260203","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/CIRCULATIONAHA.120.045723","article-title":"An international multicenter evaluation of inheritance patterns, arrhythmic risks, and underlying mechanisms of CASQ2-catecholaminergic polymorphic ventricular tachycardia.","volume":"142","author":"Ng","year":"2020","journal-title":"Circulation"},{"key":"R88-20260203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/CIRCRESAHA.108.171660","article-title":"Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model.","volume":"103","author":"Rizzi","year":"2008","journal-title":"Circ Res"},{"key":"R89-20260203","doi-asserted-by":"crossref","first-page":"4083","DOI":"10.1529\/biophysj.107.114546","article-title":"Enhanced ryanodine receptor-mediated calcium leak determines reduced sarcoplasmic reticulum calcium content in chronic canine heart failure.","volume":"93","author":"Belevych","year":"2007","journal-title":"Biophys J"},{"key":"R90-20260203","doi-asserted-by":"crossref","first-page":"18115","DOI":"10.1038\/s41598-020-75097-3","article-title":"Phylogenetic and biochemical analysis of calsequestrin structure and association of its variants with cardiac disorders.","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"R91-20260203","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s10974-020-09587-2","article-title":"Molecular adaptation to calsequestrin 2 (CASQ2) point mutations leading to catecholaminergic polymorphic ventricular tachycardia (CPVT): comparative analysis of R33Q and D307H mutants.","volume":"41","author":"Valle","year":"2020","journal-title":"J Muscle Res Cell Motil"},{"key":"R92-20260203","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1042\/BJ20101771","article-title":"Probing cationic selectivity of cardiac calsequestrin and its CPVT mutants.","volume":"435","author":"Bal","year":"2011","journal-title":"Biochem J"},{"key":"R93-20260203","doi-asserted-by":"crossref","first-page":"H253","DOI":"10.1152\/ajpheart.00578.2011","article-title":"Functional consequences of stably expressing a mutant calsequestrin (CASQ2D307H) in the CASQ2 null background.","volume":"302","author":"Kalyanasundaram","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R94-20260203","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardiores.2004.09.009","article-title":"Calsequestrin mutant D307H exhibits depressed binding to its protein targets and a depressed response to calcium.","volume":"64","author":"Houle","year":"2004","journal-title":"Cardiovasc Res"},{"key":"R95-20260203","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jmb.2007.08.055","article-title":"Characterization of human cardiac calsequestrin and its deleterious mutants.","volume":"373","author":"Kim","year":"2007","journal-title":"J Mol Biol"},{"key":"R96-20260203","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1540-8159.2008.01111.x","article-title":"A case of catecholaminergic polymorphic ventricular tachycardia caused by two calsequestrin 2 mutations.","volume":"31","author":"de la Fuente","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"R97-20260203","doi-asserted-by":"crossref","first-page":"642141","DOI":"10.3389\/fcell.2021.642141","article-title":"Association study of genetic variants in calcium signaling-related genes with cardiovascular diseases.","volume":"9","author":"Li","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"R98-20260203","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.hrthm.2014.01.015","article-title":"Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease.","volume":"11","author":"Refaat","year":"2014","journal-title":"Heart Rhythm"},{"key":"R99-20260203","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1042\/BCJ20180545","article-title":"Ca(2+)-dependent calmodulin binding to cardiac ryanodine receptor (RyR2) calmodulin-binding domains.","volume":"476","author":"Brohus","year":"2019","journal-title":"Biochem J"},{"key":"R100-20260203","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCGENETICS.115.001323","article-title":"Spectrum and prevalence of CALM1-, CALM2-, and CALM3-encoded calmodulin variants in long QT syndrome and functional characterization of a novel long QT syndrome-associated calmodulin missense variant, E141G.","volume":"9","author":"Boczek","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"key":"R101-20260203","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1093\/hmg\/ddad042","article-title":"Human calmodulin mutations cause arrhythmia and affect neuronal function in C. elegans.","volume":"32","author":"Jensen","year":"2023","journal-title":"Hum Mol Genet"},{"key":"R102-20260203","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry.","volume":"40","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"R103-20260203","doi-asserted-by":"crossref","first-page":"e004163","DOI":"10.1161\/CIRCGEN.123.004163","article-title":"Calmodulinopathy associated long QT syndrome, hypertrophic cardiomyopathy with excessive trabeculation in a 14-year-old girl presenting with ventricular fibrillation.","volume":"17","author":"Shauer","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"R104-20260203","doi-asserted-by":"crossref","first-page":"E10556","DOI":"10.1073\/pnas.1808733115","article-title":"Arrhythmia mutations in calmodulin cause conformational changes that affect interactions with the cardiac voltage-gated calcium channel.","volume":"115","author":"Wang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R105-20260203","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.bbagen.2015.07.001","article-title":"Distinctive malfunctions of calmodulin mutations associated with heart RyR2-mediated arrhythmic disease.","volume":"1850","author":"Vassilakopoulou","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"R106-20260203","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.febslet.2014.07.007","article-title":"Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death.","volume":"588","author":"Nomikos","year":"2014","journal-title":"FEBS Lett"},{"key":"R107-20260203","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/nyas.14033","article-title":"Arrhythmogenic calmodulin E105A mutation alters cardiac RyR2 regulation leading to cardiac dysfunction in zebrafish.","volume":"1448","author":"Da\u2019as","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"R108-20260203","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1074\/jbc.RA120.013430","article-title":"The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor.","volume":"295","author":"Holt","year":"2020","journal-title":"J Biol Chem"},{"key":"R109-20260203","doi-asserted-by":"crossref","first-page":"1100992","DOI":"10.3389\/fmolb.2022.1100992","article-title":"Calmodulin variants associated with congenital arrhythmia impair selectivity for ryanodine receptors.","volume":"9","author":"Dal Cortivo","year":"2022","journal-title":"Front Mol Biosci"},{"key":"R110-20260203","doi-asserted-by":"crossref","first-page":"102777","DOI":"10.1016\/j.jbc.2022.102777","article-title":"Calmodulin variant E140G associated with long QT syndrome impairs CaMKII\u03b4 autophosphorylation and L-type calcium channel inactivation.","volume":"299","author":"Prakash","year":"2023","journal-title":"J Biol Chem"},{"key":"R111-20260203","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0006-291X(03)00406-6","article-title":"Human skeletal muscle triadin: gene organization and cloning of the major isoform, Trisk 51.","volume":"303","author":"Thevenon","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R112-20260203","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.hrthm.2019.08.018","article-title":"A novel homozygous mutation in the TRDN gene causes a severe form of pediatric malignant ventricular arrhythmia.","volume":"17","author":"Rossi","year":"2020","journal-title":"Heart Rhythm"},{"key":"R113-20260203","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/ajmg.a.62464","article-title":"Novel cases of pediatric sudden cardiac death secondary to TRDN mutations presenting as long QT syndrome at rest and catecholaminergic polymorphic ventricular tachycardia during exercise: the TRDN arrhythmia syndrome.","volume":"185","author":"Rabbani","year":"2021","journal-title":"Am J Med Genet A"},{"key":"R114-20260203","doi-asserted-by":"crossref","first-page":"7636","DOI":"10.1073\/pnas.0902919106","article-title":"Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias.","volume":"106","author":"Chopra","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R115-20260203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/pace.12813","article-title":"Compound heterozygous triadin mutation causing cardiac arrest in two siblings.","volume":"39","author":"Walsh","year":"2016","journal-title":"Pacing Clin Electrophysiol"},{"key":"R116-20260203","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.hrthm.2020.01.012","article-title":"Phenotype-guided whole genome analysis in a patient with genetically elusive long QT syndrome yields a novel TRDN-encoded triadin pathogenetic substrate for triadin knockout syndrome and reveals a novel primate-specific cardiac TRDN transcript.","volume":"17","author":"Clemens","year":"2020","journal-title":"Heart Rhythm"},{"key":"R117-20260203","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.stemcr.2023.04.005","article-title":"Cellular and electrophysiological characterization of triadin knockout syndrome using induced pluripotent stem cell-derived cardiomyocytes.","volume":"18","author":"Clemens","year":"2023","journal-title":"Stem Cell Rep"},{"key":"R118-20260203","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1017\/S1047951122001226","article-title":"A very rare cause of sudden cardiac arrest in children: triadin knockout syndrome.","volume":"33","author":"Sulu","year":"2023","journal-title":"Cardiol Young"},{"key":"R119-20260203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/jce.14446","article-title":"Novel variants in TECRL cause recessive inherited CPVT type 3 with severe and variable clinical symptoms.","volume":"31","author":"Moscu-Gregor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R120-20260203","doi-asserted-by":"crossref","first-page":"103028","DOI":"10.1016\/j.fsigen.2024.103028","article-title":"Recurrent familial case of early childhood sudden death: complex post mortem genetic investigations.","volume":"71","author":"Krebs-Drouot","year":"2024","journal-title":"Forensic Sci Int Genet"},{"key":"R121-20260203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/s42003-022-03414-9","article-title":"TECRL deficiency results in aberrant mitochondrial function in cardiomyocytes.","volume":"5","author":"Hou","year":"2022","journal-title":"Commun Biol"},{"key":"R122-20260203","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/europace\/euaa376","article-title":"Life-threatening arrhythmias with autosomal recessive TECRL variants.","volume":"23","author":"Webster","year":"2021","journal-title":"Europace"},{"key":"R123-20260203","doi-asserted-by":"crossref","first-page":"e202402572","DOI":"10.26508\/lsa.202402572","article-title":"Novel variants in TECRL leading to catecholaminergic polymorphic ventricular tachycardia.","volume":"7","author":"Jones","year":"2024","journal-title":"Life Sci Alliance"},{"key":"R124-20260203","doi-asserted-by":"crossref","first-page":"20230880","DOI":"10.1515\/med-2023-0880","article-title":"Transcriptome analysis of effects of Tecrl deficiency on cardiometabolic and calcium regulation in cardiac tissue.","volume":"19","author":"Lin","year":"2024","journal-title":"Open Med (Wars)"},{"key":"R125-20260203","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry.","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"key":"R126-20260203","doi-asserted-by":"crossref","first-page":"e001424","DOI":"10.1161\/CIRCGEN.116.001424","article-title":"Yield of the RYR2 genetic test in suspected catecholaminergic polymorphic ventricular tachycardia and implications for test interpretation.","volume":"11","author":"Kapplinger","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"R127-20260203","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1253\/circj.CJ-16-0326","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"80","author":"Lieve","year":"2016","journal-title":"Circ J"},{"key":"R128-20260203","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.hrthm.2016.05.004","article-title":"A novel heterozygous mutation in cardiac calsequestrin causes autosomal dominant catecholaminergic polymorphic ventricular tachycardia.","volume":"13","author":"Gray","year":"2016","journal-title":"Heart Rhythm"},{"key":"R129-20260203","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1086\/324565","article-title":"A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel.","volume":"69","author":"Lahat","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R130-20260203","doi-asserted-by":"crossref","first-page":"103631","DOI":"10.1016\/j.ejmg.2019.01.018","article-title":"A compound heterozygosity of Tecrl gene confirmed in a catecholaminergic polymorphic ventricular tachycardia family.","volume":"62","author":"Xie","year":"2019","journal-title":"Eur J Med Genet"},{"key":"R131-20260203","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1113\/JP276757","article-title":"Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia.","volume":"598","author":"Wleklinski","year":"2020","journal-title":"J Physiol"},{"key":"R132-20260203","doi-asserted-by":"crossref","first-page":"a003996","DOI":"10.1101\/cshperspect.a003996","article-title":"Ryanodine receptors: structure, expression, molecular details, and function in calcium release.","volume":"2","author":"Lanner","year":"2010","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"R133-20260203","doi-asserted-by":"crossref","first-page":"35554","DOI":"10.1074\/jbc.M707788200","article-title":"Transcriptional analysis of the human cardiac calsequestrin gene in cardiac and skeletal myocytes.","volume":"282","author":"Reyes-Ju\u00e1rez","year":"2007","journal-title":"J Biol Chem"},{"key":"R134-20260203","doi-asserted-by":"crossref","first-page":"102656","DOI":"10.1016\/j.ceca.2022.102656","article-title":"Differential expression of the three independent CaM genes coding for an identical protein: potential relevance of distinct mRNA stability by different codon usage.","volume":"107","author":"Munk","year":"2022","journal-title":"Cell Calcium"},{"key":"R135-20260203","doi-asserted-by":"crossref","first-page":"2165278","DOI":"10.1080\/19336950.2023.2165278","article-title":"Calmodulin mutations in human disease.","volume":"17","author":"Hussey","year":"2023","journal-title":"Channels (Austin)"},{"key":"R136-20260203","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.3390\/biom12081030","article-title":"Molecular, subcellular, and arrhythmogenic mechanisms in genetic RyR2 disease.","volume":"12","author":"Fowler","year":"2022","journal-title":"Biomolecules"},{"key":"R137-20260203","doi-asserted-by":"crossref","first-page":"649688","DOI":"10.3389\/fnins.2021.649688","article-title":"Triadin decrease impairs the expression of E-C coupling related proteins in muscles of MPTP-induced Parkinson\u2019s disease mice.","volume":"15","author":"Seo","year":"2021","journal-title":"Front Neurosci"},{"key":"R138-20260203","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.hrthm.2006.03.025","article-title":"Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.","volume":"3","author":"Tester","year":"2006","journal-title":"Heart Rhythm"},{"key":"R139-20260203","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2024.01.003","article-title":"Dual effect of cardiac FKBP12.6 overexpression on excitation-contraction coupling and the incidence of ventricular arrhythmia depending on its expression level.","volume":"188","author":"Gandon-Renard","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"R140-20260203","doi-asserted-by":"crossref","first-page":"e202112869","DOI":"10.1085\/jgp.202112869","article-title":"Cytosolic Ca2+-dependent Ca2+ release activity primarily determines the ER Ca2+ level in cells expressing the CPVT-linked mutant RYR2.","volume":"154","author":"Kurebayashi","year":"2022","journal-title":"J Gen Physiol"},{"key":"R141-20260203","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jelectrocard.2015.06.005","article-title":"Arrythmogenic right ventricular dysplasia\/cardiomyopathy (ARVD\/C) and cathecholaminergic polymorphic ventricular tachycardia (CPVT): a phenotypic spectrum seen in same patient.","volume":"48","author":"Patel","year":"2015","journal-title":"J Electrocardiol"},{"key":"R142-20260203","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1152\/japplphysiol.00818.2012","article-title":"Exercise training improves cardiac function and attenuates arrhythmia in CPVT mice.","volume":"113","author":"Kurtzwald-Josefson","year":"2012","journal-title":"J Appl Physiol (1985)"},{"key":"R143-20260203","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.hrthm.2017.10.008","article-title":"Accentuated vagal antagonism paradoxically increases ryanodine receptor calcium leak in long-term exercised Calsequestrin2 knockout mice.","volume":"15","author":"Ho","year":"2018","journal-title":"Heart Rhythm"},{"key":"R144-20260203","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/eurheartj\/ehl543","article-title":"Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves.","volume":"28","author":"Paavola","year":"2007","journal-title":"Eur Heart J"},{"key":"R145-20260203","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1159\/000322318","article-title":"Modulation of human ether a gogo related channels by CASQ2 contributes to etiology of catecholaminergic polymorphic ventricular tachycardia (CPVT).","volume":"26","author":"Eckey","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"R146-20260203","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/febs.13184","article-title":"Calmodulin mutations causing catecholaminergic polymorphic ventricular tachycardia confer opposing functional and biophysical molecular changes.","volume":"282","author":"S\u00f8ndergaard","year":"2015","journal-title":"FEBS J"},{"key":"R147-20260203","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling.","volume":"415","author":"Bers","year":"2002","journal-title":"Nature"},{"key":"R148-20260203","doi-asserted-by":"crossref","first-page":"208a","DOI":"10.1016\/j.bpj.2024.11.1153","article-title":"BPS2025 - RyR2-V2475F mutation in rabbit alters cardiomyocyte electrophysiology.","volume":"124","author":"G\u00e9rard","year":"2025","journal-title":"Biophys J"},{"key":"R149-20260203","doi-asserted-by":"crossref","first-page":"e011387","DOI":"10.1161\/CIRCEP.122.011387","article-title":"Novel calmodulin variant p.E46K associated with severe catecholaminergic polymorphic ventricular tachycardia produces robust arrhythmogenicity in human induced pluripotent stem cell-derived cardiomyocytes.","volume":"16","author":"Gao","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R150-20260203","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCULATIONAHA.119.039711","article-title":"Insights into the pathogenesis of catecholaminergic polymorphic ventricular tachycardia from engineered human heart tissue.","volume":"140","author":"Park","year":"2019","journal-title":"Circulation"},{"key":"R151-20260203","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCRESAHA.110.227744","article-title":"In the RyR2(R4496C) mouse model of CPVT, \u03b2-adrenergic stimulation induces Ca waves by increasing SR Ca content and not by decreasing the threshold for Ca waves.","volume":"107","author":"Kashimura","year":"2010","journal-title":"Circ Res"},{"key":"R152-20260203","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/01.RES.79.6.1100","article-title":"Regulation of cardiac Ca2+ release channel (ryanodine receptor) by Ca2+, H+, Mg2+, and adenine nucleotides under normal and simulated ischemic conditions.","volume":"79","author":"Xu","year":"1996","journal-title":"Circ Res"},{"key":"R153-20260203","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)80847-8","article-title":"PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.","volume":"101","author":"Marx","year":"2000","journal-title":"Cell"},{"key":"R154-20260203","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/bi015581z","article-title":"Spectroscopic monitoring of local conformational changes during the intramolecular domain-domain interaction of the ryanodine receptor.","volume":"41","author":"Yamamoto","year":"2002","journal-title":"Biochemistry"},{"key":"R155-20260203","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1161\/CIRCULATIONAHA.104.507921","article-title":"Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure.","volume":"111","author":"Oda","year":"2005","journal-title":"Circulation"},{"key":"R156-20260203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature09471","article-title":"The amino-terminal disease hotspot of ryanodine receptors forms a cytoplasmic vestibule.","volume":"468","author":"Tung","year":"2010","journal-title":"Nature"},{"key":"R157-20260203","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.str.2009.08.016","article-title":"Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.","volume":"17","author":"Lobo","year":"2009","journal-title":"Structure"},{"key":"R158-20260203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2174\/1874467208666150519113541","article-title":"FK506-binding proteins and their diverse functions.","volume":"9","author":"Tong","year":"2015","journal-title":"Curr Mol Pharmacol"},{"key":"R159-20260203","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41569-020-0394-8","article-title":"Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target.","volume":"17","author":"Dridi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"R160-20260203","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jmb.2005.12.023","article-title":"Structural characterization of the RyR1-FKBP12 interaction.","volume":"356","author":"Sams\u00f3","year":"2006","journal-title":"J Mol Biol"},{"key":"R161-20260203","doi-asserted-by":"crossref","first-page":"e85","DOI":"10.1371\/journal.pbio.1000085","article-title":"Coordinated movement of cytoplasmic and transmembrane domains of RyR1 upon gating.","volume":"7","author":"Sams\u00f3","year":"2009","journal-title":"PLoS Biol"},{"key":"R162-20260203","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1038\/ncomms8947","article-title":"Crystal structures of ryanodine receptor SPRY1 and tandem-repeat domains reveal a critical FKBP12 binding determinant.","volume":"6","author":"Yuchi","year":"2015","journal-title":"Nat Commun"},{"key":"R163-20260203","doi-asserted-by":"crossref","first-page":"H1987","DOI":"10.1152\/ajpheart.00409.2004","article-title":"FKBP12.6 overexpression decreases Ca2+ spark amplitude but enhances [Ca2+]i transient in rat cardiac myocytes.","volume":"287","author":"G\u00f3mez","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R164-20260203","first-page":"332","article-title":"Sensitized signalling between L-type Ca2+ channels and ryanodine receptors in the absence or inhibition of FKBP12.6 in cardiomyocytes.","volume":"113","author":"Zhao","year":"2017","journal-title":"Cardiovasc Res"},{"key":"R165-20260203","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/01.RES.0000258468.31815.42","article-title":"Mechanisms of abnormal calcium homeostasis in mutations responsible for catecholaminergic polymorphic ventricular tachycardia.","volume":"100","author":"Iyer","year":"2007","journal-title":"Circ Res"},{"key":"R166-20260203","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1113\/jphysiol.2007.136879","article-title":"Protein protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes.","volume":"583","author":"Terentyev","year":"2007","journal-title":"J Physiol"},{"key":"R167-20260203","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","article-title":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia.","volume":"21","author":"Pflaumer","year":"2012","journal-title":"Heart Lung Circ"},{"key":"R168-20260203","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias.","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"R169-20260203","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1161\/CIRCEP.111.962027","article-title":"Catecholaminergic polymorphic ventricular tachycardia.","volume":"5","author":"Leenhardt","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R170-20260203","first-page":"7","article-title":"Cardiac channelopathies and sudden death: recent clinical and genetic advances.","volume":"6","author":"Fern\u00e1ndez-Falgueras","year":"2017","journal-title":"Biology (Basel)"},{"key":"R171-20260203","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.hrthm.2013.08.022","article-title":"Familial cardiological and targeted genetic evaluation: low yield in sudden unexplained death and high yield in unexplained cardiac arrest syndromes.","volume":"10","author":"Kumar","year":"2013","journal-title":"Heart Rhythm"},{"key":"R172-20260203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.hlc.2019.10.014","article-title":"Genetic testing in inherited heart diseases.","volume":"29","author":"Ingles","year":"2020","journal-title":"Heart Lung Circ"},{"key":"R173-20260203","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013.","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm"},{"key":"R174-20260203","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"R175-20260203","doi-asserted-by":"crossref","first-page":"S0025","DOI":"10.1016\/j.mayocp.2016.08.008","article-title":"The promise and peril of precision medicine: phenotyping still matters most.","volume":"91","author":"Ackerman","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"R176-20260203","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: are all beta-blockers equivalent?","volume":"14","author":"Ackerman","year":"2017","journal-title":"Heart Rhythm"},{"key":"R177-20260203","doi-asserted-by":"crossref","first-page":"e12512","DOI":"10.1111\/anec.12512","article-title":"Catecholaminergic polymorphic ventricular tachycardia, an update.","volume":"23","author":"P\u00e9rez-Riera","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"R178-20260203","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCULATIONAHA.121.056018","article-title":"An international multicenter cohort study on \u03b2-blockers for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.","volume":"145","author":"Peltenburg","year":"2022","journal-title":"Circulation"},{"key":"R179-20260203","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/bcp.12267","article-title":"Paediatric pharmacokinetics: key considerations.","volume":"79","author":"Batchelor","year":"2015","journal-title":"Br J Clin Pharmacol"},{"key":"R180-20260203","first-page":"100264","article-title":"Approach to inherited arrhythmias in pregnancy.","volume":"5","author":"Albertini","year":"2021","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"R181-20260203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15420\/aer.2016.3.3","article-title":"The role of flecainide in the management of catecholaminergic polymorphic ventricular tachycardia.","volume":"5","author":"Lieve","year":"2016","journal-title":"Arrhythm Electrophysiol Rev"},{"key":"R182-20260203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1161\/CIRCRESAHA.120.316819","article-title":"RYR2 channel inhibition is the principal mechanism of flecainide action in CPVT.","volume":"128","author":"Kryshtal","year":"2021","journal-title":"Circ Res"},{"key":"R183-20260203","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/CIRCRESAHA.111.247338","article-title":"Short communication: flecainide exerts an antiarrhythmic effect in a mouse model of catecholaminergic polymorphic ventricular tachycardia by increasing the threshold for triggered activity.","volume":"109","author":"Liu","year":"2011","journal-title":"Circ Res"},{"key":"R184-20260203","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nm.1942","article-title":"Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans.","volume":"15","author":"Watanabe","year":"2009","journal-title":"Nat Med"},{"key":"R185-20260203","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: a randomized clinical trial.","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"R186-20260203","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.","volume":"57","author":"van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R187-20260203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1046\/j.1540-8167.2005.40516.x","article-title":"Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.","volume":"16","author":"Swan","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R188-20260203","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.hrthm.2007.05.017","article-title":"Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Rosso","year":"2007","journal-title":"Heart Rhythm"},{"key":"R189-20260203","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1016\/j.hrthm.2010.07.004","article-title":"Optimizing catecholaminergic polymorphic ventricular tachycardia therapy in calsequestrin-mutant mice.","volume":"7","author":"Katz","year":"2010","journal-title":"Heart Rhythm"},{"key":"R190-20260203","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.hlc.2016.01.012","article-title":"Clinical challenges in catecholaminergic polymorphic ventricular tachycardia.","volume":"25","author":"Imberti","year":"2016","journal-title":"Heart Lung Circ"},{"key":"R191-20260203","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.joa.2015.08.002","article-title":"Left cardiac sympathetic denervation: an important treatment option for patients with hereditary ventricular arrhythmias.","volume":"32","author":"Cho","year":"2016","journal-title":"J Arrhythm"},{"key":"R192-20260203","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: the role of left cardiac sympathetic denervation.","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"R193-20260203","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1056\/NEJMoa0708006","article-title":"Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia.","volume":"358","author":"Wilde","year":"2008","journal-title":"N Engl J Med"},{"key":"R194-20260203","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12471-014-0523-2","article-title":"Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes.","volume":"22","author":"Olde Nordkamp","year":"2014","journal-title":"Neth Heart J"},{"key":"R195-20260203","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.hrthm.2019.06.018","article-title":"Cardiac sympathetic denervation for refractory ventricular arrhythmias in patients with structural heart disease: a systematic review.","volume":"16","author":"Shah","year":"2019","journal-title":"Heart Rhythm"},{"key":"R196-20260203","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 European Society of Cardiology guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs.","volume":"36","author":"Priori","year":"2015","journal-title":"Eur Heart J"}],"container-title":["Asian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ah9.0000000000000018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:02:20Z","timestamp":1770120140000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/ah9.0000000000000018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":196,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/ah9.0000000000000018","relation":{},"ISSN":["3007-066X","3065-2693"],"issn-type":[{"value":"3007-066X","type":"print"},{"value":"3065-2693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}